Skip to Main Content


Addictive Behaviors | Alcohol Addiction | Mental Health & Behavioral Research, Phase I-II

Prazosin for Alcohol Use Disorder

What is the purpose of this trial?

The purpose of this 12-week study is to see if a medication called Prazosin, which is an FDA approved medication for blood pressure, reduces alcohol intake and the desire to use alcohol in individuals with alcohol use disorder who have experienced some withdrawal symptoms now or in the past. We are trying to see if it will prevent or reduce alcohol intake and relapse, especially those related to stress and anxiety.

Participation involves weekly or biweekly visits to the Yale Stress Center in New Haven, as well as free weekly counseling sessions. Total estimated compensation is $830.

For information contact: Yale Stress Center at 1-877-Y-STUDIES (1-877-978-8343) or 203-737-5201,

Contact Information

For more information about this study, including how to volunteer, contact Yale Stress Center

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC